{"id":"https://openalex.org/W2748855453","doi":null,"title":"Philadelphia chromosome-like acute lymphoblastic leukemia: progress in a new cancer subtype.","display_name":"Philadelphia chromosome-like acute lymphoblastic leukemia: progress in a new cancer subtype.","alternate_titles":[],"publication_year":2017,"publication_date":"2017-07-01","ids":{"openalex":"https://openalex.org/W2748855453","mag":"2748855453","pmid":"https://pubmed.ncbi.nlm.nih.gov/28749919"},"language":"en","primary_location":{"id":"pmid:28749919","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28749919","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical advances in hematology & oncology : H&O","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W2748855453"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011944832","display_name":"Julia E. Wells","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julia Wells","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021380291","display_name":"Nitin Jain","orcid":"https://orcid.org/0000-0003-0114-8384","observed_orcids":["https://orcid.org/0000-0003-0114-8384"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nitin Jain","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022647201","display_name":"Marina Y Konopleva","orcid":"https://orcid.org/0000-0002-9347-2212","observed_orcids":["https://orcid.org/0000-0002-9347-2212"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marina Konopleva","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":null,"apc_paid":null,"fwci":2.2718,"has_fulltext":false,"cited_by_count":28,"citation_normalized_percentile":{"value":0.88920535,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"15","issue":"7","first_page":"554","last_page":"561"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/philadelphia-chromosome-like-acute-lymphoblastic-leukemia","display_name":"Philadelphia chromosome-like acute lymphoblastic leukemia","score":0.9959999918937683},{"id":"https://openalex.org/keywords/b-cell-acute-lymphoblastic-leukemia","display_name":"B-cell acute lymphoblastic leukemia","score":0.9789999723434448},{"id":"https://openalex.org/keywords/bcr-abl-fusion","display_name":"BCR-ABL fusion gene","score":0.8610000014305115},{"id":"https://openalex.org/keywords/gene-expression-profiles","display_name":"gene expression profiles","score":0.7580000162124634},{"id":"https://openalex.org/keywords/who-classification-of-myeloid-neoplasms","display_name":"WHO classification of myeloid neoplasms","score":0.8349999785423279},{"id":"https://openalex.org/keywords/genomic-rearrangements","display_name":"genome rearrangement","score":0.8500000238418579},{"id":"https://openalex.org/keywords/mutation","display_name":"genetic mutations","score":0.6480000019073486},{"id":"https://openalex.org/keywords/incidence","display_name":"incidence","score":0.675000011920929},{"id":"https://openalex.org/keywords/clinical-outcomes","display_name":"clinical outcomes","score":0.8640000224113464},{"id":"https://openalex.org/keywords/ruxolitinib","display_name":"ruxolitinib","score":0.996999979019165},{"id":"https://openalex.org/keywords/dasatinib","display_name":"dasatinib","score":0.9459999799728394},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.8659999966621399}],"concepts":[{"id":"https://openalex.org/C2779536868","wikidata":"https://www.wikidata.org/wiki/Q419940","display_name":"Dasatinib","level":4,"score":0.8648331761360168},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7888268232345581},{"id":"https://openalex.org/C2778904597","wikidata":"https://www.wikidata.org/wiki/Q1129111","display_name":"Philadelphia chromosome","level":4,"score":0.7513364553451538},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.6706011295318604},{"id":"https://openalex.org/C111829193","wikidata":"https://www.wikidata.org/wiki/Q1108970","display_name":"Fusion gene","level":3,"score":0.6447969079017639},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6284606456756592},{"id":"https://openalex.org/C125418893","wikidata":"https://www.wikidata.org/wiki/Q587961","display_name":"ABL","level":4,"score":0.5820938944816589},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.5755113363265991},{"id":"https://openalex.org/C2776407475","wikidata":"https://www.wikidata.org/wiki/Q1981783","display_name":"Pathognomonic","level":3,"score":0.5487672686576843},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.5067926049232483},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4299049377441406},{"id":"https://openalex.org/C2909962599","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Lymphoblastic Leukemia","level":3,"score":0.41929590702056885},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.3981664776802063},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3664588928222656},{"id":"https://openalex.org/C138626823","wikidata":"https://www.wikidata.org/wiki/Q916504","display_name":"Chromosomal translocation","level":3,"score":0.35343605279922485},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.3533281683921814},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3236646056175232},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.23748043179512024},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.23674622178077698},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2347816526889801},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.11106613278388977},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069439","descriptor_name":"Dasatinib","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010677","descriptor_name":"Philadelphia Chromosome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015321","descriptor_name":"Gene Rearrangement","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015973","descriptor_name":"Gene Expression Regulation, Leukemic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016044","descriptor_name":"Fusion Proteins, bcr-abl","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D016044","descriptor_name":"Fusion Proteins, bcr-abl","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D053612","descriptor_name":"Janus Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D054198","descriptor_name":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D054198","descriptor_name":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D054198","descriptor_name":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D054198","descriptor_name":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:28749919","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28749919","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical advances in hematology & oncology : H&O","raw_type":"Journal Article"},{"id":"mag:2748855453","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28749919","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":63,"referenced_works":["https://openalex.org/W44534308","https://openalex.org/W1499446950","https://openalex.org/W1541521552","https://openalex.org/W1569839307","https://openalex.org/W1582130462","https://openalex.org/W1848034928","https://openalex.org/W1853602163","https://openalex.org/W1984684983","https://openalex.org/W1986495031","https://openalex.org/W1987294127","https://openalex.org/W1991003544","https://openalex.org/W1994568187","https://openalex.org/W1998593414","https://openalex.org/W2004097969","https://openalex.org/W2007348709","https://openalex.org/W2012114257","https://openalex.org/W2016086822","https://openalex.org/W2016830328","https://openalex.org/W2020092689","https://openalex.org/W2021782220","https://openalex.org/W2026966240","https://openalex.org/W2034920499","https://openalex.org/W2036999612","https://openalex.org/W2037104393","https://openalex.org/W2043235003","https://openalex.org/W2047623360","https://openalex.org/W2062043705","https://openalex.org/W2068209691","https://openalex.org/W2069709802","https://openalex.org/W2073878519","https://openalex.org/W2074465378","https://openalex.org/W2075043727","https://openalex.org/W2084041698","https://openalex.org/W2087497315","https://openalex.org/W2092157777","https://openalex.org/W2096709475","https://openalex.org/W2119240494","https://openalex.org/W2128491464","https://openalex.org/W2138218344","https://openalex.org/W2148202982","https://openalex.org/W2154564841","https://openalex.org/W2154947819","https://openalex.org/W2162696088","https://openalex.org/W2163001955","https://openalex.org/W2163176957","https://openalex.org/W2166807441","https://openalex.org/W2291203819","https://openalex.org/W2326217500","https://openalex.org/W2329648702","https://openalex.org/W2339658711","https://openalex.org/W2345348011","https://openalex.org/W2346531348","https://openalex.org/W2391917737","https://openalex.org/W2417668004","https://openalex.org/W2423236461","https://openalex.org/W2464630776","https://openalex.org/W2517252743","https://openalex.org/W2534055440","https://openalex.org/W2554580516","https://openalex.org/W2554992607","https://openalex.org/W2564312835","https://openalex.org/W2602726122","https://openalex.org/W4238491931"],"related_works":["https://openalex.org/W2762869808","https://openalex.org/W3165266810","https://openalex.org/W4387099348","https://openalex.org/W2999923987","https://openalex.org/W2806076094","https://openalex.org/W4206623531","https://openalex.org/W2726804531","https://openalex.org/W7133959356","https://openalex.org/W4362657436","https://openalex.org/W4311679896"],"abstract_inverted_index":{"Philadelphia":[0],"chromosome-like":[1],"(Ph-like)":[2],"acute":[3,46],"lymphoblastic":[4],"leukemia":[5,47],"(ALL)":[6],"is":[7,17,34,70,79],"a":[8,20,63,82],"newly":[9],"described,":[10],"high-risk":[11],"subtype":[12,58],"of":[13,27,42,59,84,100,115],"B-cell":[14,60],"ALL.":[15],"It":[16],"characterized":[18,71,80],"by":[19,72,81],"gene":[21],"expression":[22],"profile":[23],"similar":[24],"to":[25,51],"that":[26],"Ph-positive":[28,67],"ALL;":[29],"however,":[30],"the":[31,53,73,95,103,113],"BCR-ABL1":[32,75],"fusion":[33],"not":[35],"present.":[36],"The":[37],"World":[38],"Health":[39],"Organization":[40],"classification":[41],"myeloid":[43],"neoplasms":[44],"and":[45,88,97,109,122],"recently":[48],"was":[49],"updated":[50],"include":[52],"Ph-like":[54,77,101],"or":[55],"BCR-ABL1-like":[56],"ALL":[57,61,78],"as":[62],"provisional":[64],"entity.":[65],"Unlike":[66],"ALL,":[68,102],"which":[69],"pathognomonic":[74],"fusion,":[76],"multitude":[83],"different":[85],"genetic":[86],"rearrangements":[87],"mutations.":[89],"In":[90],"this":[91],"review,":[92],"we":[93],"outline":[94],"age-related":[96],"geographic":[98],"incidence":[99],"association":[104],"with":[105],"worse":[106],"clinical":[107],"outcomes,":[108],"early":[110],"evidence":[111],"for":[112],"use":[114],"ruxolitinib":[116],"(a":[117,124],"Janus":[118],"kinase":[119,126],"2":[120],"inhibitor)":[121],"dasatinib":[123],"tyrosine":[125],"inhibitor":[127],"targeting":[128],"ABL1).":[129]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2748855453","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2017-08-31T00:00:00"}
